Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |